Skip to content
About
Company Overview
Board of Directors
Management Team
Organization Chart
R&D
Pipeline
Pipeline Overview
Globo H
Adagloxad simolenin
(Vaccine)
OBI-833
(Vaccine)
AKR1C3
OBI-3424
(Prodrug)
TROP2
OBI-992
(ADC)
OBI-902
(ADC)
Nectin4
OBI-904
(ADC)
HER2
OBI-905
(ADC)
Technology Platform
Reference Library
News
Investors
Investor Overview
About
Company Profile
Corporate Governance
Stakeholder
News&Events
Announcements
Event Calendar
Financial Information
Annual Report
Financial Report
Monthly Revenues
Stock Quote
IR Presentation
Careers
ESG
Contact
繁體中文
About
Company Overview
Board of Directors
Management Team
Organization Chart
R&D
Pipeline
Pipeline Overview
Globo H
Adagloxad simolenin
(Vaccine)
OBI-833
(Vaccine)
AKR1C3
OBI-3424
(Prodrug)
TROP2
OBI-992
(ADC)
OBI-902
(ADC)
Nectin4
OBI-904
(ADC)
HER2
OBI-905
(ADC)
Technology Platform
Reference Library
News
Investors
Investor Overview
About
Company Profile
Corporate Governance
Stakeholder
News&Events
Announcements
Event Calendar
Financial Information
Annual Report
Financial Report
Monthly Revenues
Stock Quote
IR Presentation
Careers
ESG
Contact
繁體中文
2017-10-20
OBI Plans to Issue New Shares in Exchange for the AP Biosciences, Inc. Shares Owned by AbProtix,Inc, Subject to Regulatory Approval
Please visit
Investor Announcement page
for more detail.
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our
use of cookies
.
Cookie Settings
Accept
Manage consent
Close
必要性
必要性
Always Enabled
必要性cookies在網站內是絕對重要的功能, 此分類僅包含功能性及安全性的cookies, 此cookies不會存取任何個人隱私資料。
非必要性
非必要性
任何對於網站潛在必要性的cookies已經使用, 非必要性則為收集個資, 數據, 廣告置入等..
